Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

DVA

DaVita Inc

Dec 13 • 04:00PM ET

152.73

Dollar change -1.17
Percentage change -0.76	%

Healthcare • Medical Care Facilities • USA • NYSE

Peers: FMS DNLI OMCL MMSI BAX AMED DXCM UHS

| Held by: VTI VOO VB RSP VBR SPY IVV XLV IWP IWF

Scroll to Statements

Index	S&P 500	P/E	16.46	EPS (ttm)	9.28	Insider Own	4.51%	Shs Outstand	82.62M	Perf Week	-4.69%
Market Cap	12.52B	Forward P/E	13.45	EPS next Y	11.36	Insider Trans	-5.58%	Shs Float	78.32M	Perf Month	-2.89%
Income	827.68M	PEG	0.92	EPS next Q	2.14	Inst Own	92.45%	Short Float	4.82%	Perf Quarter	-7.54%
Sales	12.67B	P/S	0.99	EPS this Y	14.48%	Inst Trans	-3.36%	Short Ratio	4.83	Perf Half Y	8.20%
Book/sh	4.68	P/B	32.63	EPS next Y	17.13%	ROA	4.81%	Short Interest	3.78M	Perf Year	40.38%
Cash/sh	14.39	P/C	10.62	EPS next 5Y	17.90%	ROE	104.38%	52W Range	103.40 - 169.51	Perf YTD	45.79%
Dividend Est.	-	P/FCF	8.80	EPS past 5Y	51.82%	ROI	6.96%	52W High	-9.90%	Beta	0.90
Dividend TTM	-	Quick Ratio	1.33	Sales past 5Y	1.27%	Gross Margin	26.92%	52W Low	47.71%	ATR (14)	3.86
Dividend Ex-Date	-	Current Ratio	1.37	EPS Y/Y TTM	45.46%	Oper. Margin	14.88%	RSI (14)	39.05	Volatility	2.64% 2.34%
Employees	70000	Debt/Eq	31.54	Sales Y/Y TTM	6.34%	Profit Margin	6.53%	Recom	2.91	Target Price	163.00
Option/Short	Yes / Yes	LT Debt/Eq	29.73	EPS Q/Q	-4.59%	Payout	0.00%	Rel Volume	0.65	Prev Close	153.90
Sales Surprise	0.50%	EPS Surprise	-4.91%	Sales Q/Q	4.56%	Earnings	Oct 29 AMC	Avg Volume	781.20K	Price	152.73
SMA20	-5.12%	SMA50	-3.24%	SMA200	4.56%	Trades		Volume	508,604	Change	-0.76%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-06-24	Initiated	Barclays	Equal Weight	$133
Aug-07-23	Upgrade	UBS	Neutral → Buy	$100 → $142
Nov-01-22	Downgrade	Deutsche Bank	Buy → Hold	$97 → $72
Oct-31-22	Downgrade	UBS	Buy → Neutral	$117 → $74
Aug-19-22	Resumed	UBS	Buy	$106 → $117
Jun-21-22	Reiterated	BofA Securities	Underperform	$110 → $90
Sep-10-21	Initiated	Cowen	Market Perform	$145
Aug-12-21	Downgrade	Barclays	Overweight → Equal Weight	$135 → $146
Mar-26-21	Downgrade	BofA Securities	Neutral → Underperform	$127 → $118
Jan-05-21	Downgrade	BofA Securities	Buy → Neutral	$127
Jan-24-20	Upgrade	Goldman	Neutral → Buy	$72 → $97
Nov-07-19	Downgrade	Raymond James	Outperform → Mkt Perform
Oct-25-19	Downgrade	Wolfe Research	Outperform → Peer Perform
Sep-11-19	Downgrade	William Blair	Outperform → Mkt Perform
Jul-26-19	Downgrade	Robert W. Baird	Outperform → Neutral	$70 → $65
Jan-08-19	Upgrade	UBS	Sell → Neutral
Jan-03-19	Initiated	Deutsche Bank	Buy	$60
Dec-14-18	Initiated	Barclays	Overweight
Nov-28-18	Upgrade	Raymond James	Mkt Perform → Outperform
Nov-16-18	Initiated	UBS	Sell	$64

Show Previous Ratings

Nov-24-24 08:22AM	DaVita Inc. (DVA): Strategic Expansions and Financial Performance in Warren Buffett's Portfolio (Insider Monkey)
Nov-15-24 07:08PM	Analyst Report: DaVita Inc. (Morningstar Research)
05:14PM	S&P 500 Gains and Losses Today: Palantir Stock Jumps as Listing Heads to Nasdaq (Investopedia)
Nov-12-24 09:05AM	DaVita's 'Move It With Purpose' Sets Record Participation in Support of Global Health (PR Newswire)
12:58AM	Q3 2024 Nuwellis Inc Earnings Call (Thomson Reuters StreetEvents)
04:33PM	Loading…
Nov-08-24 04:33PM	DaVita Inc. to Participate in UBS Global Healthcare Conference 2024 (PR Newswire)
Oct-31-24 07:12PM	Analyst Report: DaVita Inc. (Morningstar Research)
Oct-30-24 06:38PM	Why DaVita Stock Withered on Wednesday (Motley Fool) -10.80%
10:05AM	Q3 2024 DaVita Inc Earnings Call (Thomson Reuters StreetEvents)
08:46AM	Analyst Report: DaVita Inc. (Morningstar Research)
03:14AM	DaVita Inc (DVA) Q3 2024 Earnings Call Highlights: Strong Financial Performance Amid ... (GuruFocus.com)
01:02AM	Decoding DaVita Inc (DVA): A Strategic SWOT Insight (GuruFocus.com)
Oct-29-24 11:00PM	DaVita (DVA) Q3 2024 Earnings Call Transcript (Motley Fool)
05:15PM	DaVita HealthCare (DVA) Q3 Earnings Miss Estimates (Zacks)
04:20PM	DaVita HealthCare: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Loading…
04:05PM	DaVita Inc. 3rd Quarter 2024 Results (PR Newswire)
Oct-28-24 11:05AM	DaVita Emphasizes Commitment to Whole-Person Care with Investment in National Kidney Foundation PEERS Program (PR Newswire)
Oct-23-24 06:00PM	DaVita HealthCare (DVA) Stock Moves -0.23%: What You Should Know (Zacks)
10:00AM	DaVita Research Centers on Upstream CKD Management; Access & Equity during ASN's Kidney Week 2024 (PR Newswire)
Oct-22-24 06:15PM	DaVita HealthCare (DVA) Increases Despite Market Slip: Here's What You Need to Know (Zacks)
08:00AM	DaVita celebrates kidney care community achievements in year one of largest-ever value-based care program (PR Newswire)
Oct-17-24 01:00PM	DaVita Appoints Jessica Hergenreter as Chief People Officer (PR Newswire)
Oct-16-24 06:00PM	DaVita HealthCare (DVA) Advances But Underperforms Market: Key Facts (Zacks)
10:28AM	Is DaVita Inc. (DVA) the Best Stock In Buffett Stock Portfolio? (Insider Monkey)
09:15AM	DaVita Inc. (DVA) Hit a 52 Week High, Can the Run Continue? (Zacks)
Oct-14-24 04:28PM	Nvidia And This Breakout IPO Lead Elite List Of Stocks To Watch (Investor's Business Daily)
09:40AM	Are Investors Undervaluing DaVita (DVA) Right Now? (Zacks)
Oct-11-24 03:58PM	DaVita Opens its Doors to Anyone in Florida Needing Dialysis After Hurricane Milton (PR Newswire)
Oct-10-24 06:15PM	DaVita HealthCare (DVA) Gains As Market Dips: What You Should Know (Zacks)
Oct-09-24 01:47PM	DaVita Inc. Schedules 3rd Quarter 2024 Investor Conference Call (PR Newswire)
01:38PM	Loading…
Oct-08-24 01:38PM	DaVita Prepares Thousands of Dialysis Patients for Hurricane Milton (PR Newswire)
09:45AM	Why DaVita HealthCare (DVA) is a Top Growth Stock for the Long-Term (Zacks)
Oct-03-24 06:15PM	DaVita HealthCare (DVA) Stock Moves -0.03%: What You Should Know (Zacks)
08:29AM	DaVita Inc. (DVA): A Good Breakout Stock to Invest In Right Now (Insider Monkey)
Sep-27-24 06:00PM	DaVita HealthCare (DVA) Advances While Market Declines: Some Information for Investors (Zacks)
09:40AM	Should Value Investors Buy DaVita (DVA) Stock? (Zacks)
09:40AM	Is DaVita (DVA) Stock Outpacing Its Medical Peers This Year? (Zacks)
Sep-26-24 09:50AM	DaVita Inc. (DVA): Warren Buffetts Best Stock Performer of 2024 (Insider Monkey)
Sep-24-24 06:15PM	DaVita HealthCare (DVA) Stock Sinks As Market Gains: What You Should Know (Zacks)
12:00PM	Are You Looking for a Top Momentum Pick? Why DaVita HealthCare (DVA) is a Great Choice (Zacks)
09:50AM	Why DaVita HealthCare (DVA) is a Top Momentum Stock for the Long-Term (Zacks)
Sep-18-24 06:00PM	Here's Why DaVita HealthCare (DVA) Fell More Than Broader Market (Zacks)
08:50AM	DaVita Inc. (DVA): Best Long-Term Stock to Buy According To Warren Buffett (Insider Monkey)
Sep-17-24 06:15PM	DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
09:00AM	DaVita Accelerates Commitment to Community Health with Nationwide Tour (PR Newswire)
Sep-14-24 11:22AM	Goldman Thinks DaVita Inc. (DVA) Is A Long-Term AI Stock Set To Rally Eventually (Insider Monkey)
Sep-13-24 06:59PM	Analyst Report: DaVita Inc. (Morningstar Research)
09:15AM	DaVita Inc. (DVA) Soars to 52-Week High, Time to Cash Out? (Zacks)
08:00AM	DaVita Appoints David Maughan New Chief Operating Officer, Mike Staffieri Steps into Emeritus Role (PR Newswire)
Sep-12-24 09:40AM	Here's Why DaVita HealthCare (DVA) is a Strong Value Stock (Zacks)
Sep-11-24 06:00PM	DaVita HealthCare (DVA) Gains But Lags Market: What You Should Know (Zacks)
09:40AM	Are Investors Undervaluing DaVita (DVA) Right Now? (Zacks)
Sep-10-24 12:16PM	Why IBD Stock Of The Day DaVita Spent A Month In A Buy Zone (Investor's Business Daily)
12:00PM	DaVita HealthCare (DVA) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
Sep-06-24 04:00AM	Bull of the Day: DaVita (DVA) (Zacks)
Sep-05-24 11:31AM	DaVita HealthCare (DVA) Up 13% Since Last Earnings Report: Can It Continue? (Zacks)
Sep-03-24 04:21PM	Nvidia Gets Spanked To Start September, But This Stock Stays Fresh (Investor's Business Daily)
02:55PM	Nvidia Flails As Freshpet, ServiceNow Lead 7 Stocks To Watch (Investor's Business Daily)
12:35PM	As Nvidia Stumbles, Freshpet, ServiceNow Lead 7 Stocks To Watch (Investor's Business Daily)
Aug-30-24 12:00PM	DaVita HealthCare (DVA) is a Great Momentum Stock: Should You Buy? (Zacks)
01:23AM	Insider Sale: CFO and Treasurer Joel Ackerman Sells 68,769 Shares of DaVita Inc (DVA) (GuruFocus.com)
Aug-29-24 01:16AM	Insider Sale: CEO Javier Rodriguez Sells 40,119 Shares of DaVita Inc (DVA) (GuruFocus.com)
Aug-27-24 09:40AM	Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term (Zacks)
Aug-26-24 09:40AM	Is DaVita (DVA) Stock Undervalued Right Now? (Zacks)
Aug-19-24 11:15PM	Insider Sale: COO Michael Staffieri Sells 42,119 Shares of DaVita Inc (DVA) (GuruFocus.com)
Aug-15-24 11:38PM	Insider Sale: Chief Legal & Public Affairs Officer Kathleen Waters Sells 7,857 Shares of ... (GuruFocus.com)
09:15AM	DaVita Inc. (DVA) Hits Fresh High: Is There Still Room to Run? (Zacks)
Aug-14-24 04:01PM	Breakout Watch: Medical Stock In Buy Range, Notches All-Time High (Investor's Business Daily)
12:00PM	DaVita HealthCare (DVA) Is Up 0.56% in One Week: What You Should Know (Zacks)
08:05AM	Kidney Care Leader Marches Toward Buy Point With 2 Sector Peers In Tow (Investor's Business Daily)
Aug-09-24 01:09AM	Decoding DaVita Inc (DVA): A Strategic SWOT Insight (GuruFocus.com)
Aug-08-24 05:34PM	DaVita Inc. Announces Pricing of $1.0 Billion Senior Notes Offering (PR Newswire)
09:40AM	Is DaVita (DVA) a Great Value Stock Right Now? (Zacks)
09:40AM	Are Medical Stocks Lagging DaVita (DVA) This Year? (Zacks)
09:16AM	DaVita Inc. Announces Offering of $1.0 Billion Senior Notes (PR Newswire)
Aug-07-24 02:30PM	Analyst Report: DaVita Inc. (Morningstar Research)
02:21PM	Q2 2024 DaVita Inc Earnings Call (Thomson Reuters StreetEvents)
12:55PM	DaVita (DVA) Q2 Earnings & Revenues Top Estimates, Margins Up (Zacks)
Aug-06-24 09:15PM	DaVita (DVA) Q2 2024 Earnings Call Transcript (Motley Fool)
05:44PM	DaVita lifts annual profit forecast on strong kidney dialysis services demand (Reuters)
05:15PM	DaVita HealthCare (DVA) Q2 Earnings and Revenues Surpass Estimates (Zacks)
04:13PM	DaVita HealthCare: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	DaVita Inc. 2nd Quarter 2024 Results (PR Newswire)
Aug-05-24 11:38AM	Strength in Kidney Care Likely to Aid DaVita's (DVA) Q2 Earnings (Zacks)
09:05AM	DaVita Inc (DVA) Q2 2024: Everything You Need to Know Ahead of Earnings (GuruFocus.com)
Jul-30-24 06:00PM	DaVita HealthCare (DVA) Suffers a Larger Drop Than the General Market: Key Insights (Zacks)
Jul-24-24 06:00PM	DaVita HealthCare (DVA) Gains As Market Dips: What You Should Know (Zacks)
Jul-22-24 06:15PM	DaVita HealthCare (DVA) Laps the Stock Market: Here's Why (Zacks)
Jul-18-24 02:00PM	DaVita Inc. Schedules 2nd Quarter 2024 Investor Conference Call (PR Newswire)
Jul-16-24 06:00PM	DaVita HealthCare (DVA) Rises Higher Than Market: Key Facts (Zacks)
12:14PM	DaVita (DVA) Gains 29.8% YTD: What's Driving the Stock? (Zacks)
10:20AM	Renal Denervation Devices Market Expected to Reach USD 387 Million by 2032 with a Remarkable 37.2% CAGR, According to Straits Research (GlobeNewswire)
Jul-12-24 05:41PM	Analyst Report: DaVita Inc. (Morningstar Research)
06:08AM	Here's Why You Should Add DaVita (DVA) to Your Portfolio (Zacks)
Jul-10-24 09:40AM	Here's Why DaVita HealthCare (DVA) is a Strong Value Stock (Zacks)
Jul-09-24 06:15PM	DaVita HealthCare (DVA) Surpasses Market Returns: Some Facts Worth Knowing (Zacks)
Jul-05-24 07:14PM	Analyst Report: DaVita Inc. (Morningstar Research)
Jul-04-24 07:29AM	Here's Why You Should Add DaVita (DVA) to Your Portfolio Now (Zacks)
Jun-26-24 06:15PM	DaVita HealthCare (DVA) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
09:40AM	Are Medical Stocks Lagging DaVita (DVA) This Year? (Zacks)

DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Waters Kathleen Alyce	Chief Legal & Pub. Affairs Off	Nov 27 '24	Option Exercise	108.93	8,078	879,937	97,706	Nov 27 09:47 PM
Michael Staffieri	Officer	Nov 27 '24	Proposed Sale	167.09	7,902	1,320,345		Nov 27 03:29 PM
Michael Staffieri	Officer	Nov 18 '24	Proposed Sale	157.42	7,786	1,225,664		Nov 18 04:27 PM
Michael Staffieri	Officer	Nov 14 '24	Proposed Sale	155.94	7,459	1,163,167		Nov 14 04:05 PM
ACKERMAN JOEL	CFO and Treasuer	Sep 16 '24	Option Exercise	75.95	78,999	5,999,974	185,740	Sep 17 06:08 PM
Rodriguez Javier	Chief Executive Officer	Sep 16 '24	Sale	165.05	50,000	8,252,515	837,835	Sep 17 06:07 PM
Rodriguez Javier	Chief Executive Officer	Sep 13 '24	Sale	162.85	9,881	1,609,122	887,835	Sep 17 06:07 PM
Javier Rodriguez	Officer	Sep 16 '24	Proposed Sale	165.05	50,000	8,252,514		Sep 16 05:47 PM
Michael Staffieri	Officer	Sep 16 '24	Proposed Sale	132.41	37,295	4,938,300		Sep 16 05:47 PM
Waters Kathleen Alyce	Chief Legal & Pub. Affairs Off	Aug 28 '24	Option Exercise	75.95	26,333	1,999,991	109,344	Aug 29 06:21 PM
ACKERMAN JOEL	CFO and Treasuer	Aug 27 '24	Sale	155.06	64,029	9,928,586	111,481	Aug 29 06:13 PM
ACKERMAN JOEL	CFO and Treasuer	Aug 28 '24	Sale	155.02	4,740	734,785	106,741	Aug 29 06:13 PM
Rodriguez Javier	Chief Executive Officer	Aug 26 '24	Sale	155.93	32,176	5,017,303	905,659	Aug 28 05:36 PM
Rodriguez Javier	Chief Executive Officer	Aug 27 '24	Sale	155.93	7,943	1,238,589	897,716	Aug 28 05:36 PM
Joel Ackerman	Officer	Aug 27 '24	Proposed Sale	155.00	73,647	11,415,285		Aug 27 04:21 PM
Javier Rodriguez	Officer	Aug 26 '24	Proposed Sale	155.93	50,000	7,796,500		Aug 26 05:34 PM
NEHRA JOHN M	former board member	Aug 26 '24	Proposed Sale	153.90	30,000	4,616,967		Aug 26 03:42 PM
Rodriguez Javier	Chief Executive Officer	Aug 20 '24	Option Exercise	67.80	750,000	50,850,000	1,453,929	Aug 22 05:38 PM
STAFFIERI MICHAEL DAVID	Chief Operating Officer, DKC	Aug 16 '24	Sale	150.17	32,580	4,892,382	209,365	Aug 19 06:35 PM
STAFFIERI MICHAEL DAVID	Chief Operating Officer, DKC	Aug 15 '24	Sale	150.03	9,539	1,431,126	241,945	Aug 19 06:35 PM
Waters Kathleen Alyce	Chief Legal & Pub. Affairs Off	Aug 13 '24	Sale	146.21	7,857	1,148,766	83,011	Aug 15 06:05 PM
Michael Staffieri	Officer	Aug 15 '24	Proposed Sale	150.01	42,119	6,318,271		Aug 15 04:16 PM
Kathleen Waters	Officer	Aug 13 '24	Proposed Sale	146.20	7,857	1,148,724		Aug 13 04:10 PM
DESOER BARBARA J	Director	May 10 '24	Sale	138.81	5,030	698,214	10,954	May 14 05:44 PM
STAFFIERI MICHAEL DAVID	Chief Operating Officer, DKC	Mar 13 '24	Option Exercise	52.41	50,000	2,620,500	102,748	Mar 15 06:13 PM
STAFFIERI MICHAEL DAVID	Chief Operating Officer, DKC	Mar 06 '24	Option Exercise	52.41	50,000	2,620,500	87,687	Mar 08 05:05 PM
ACKERMAN JOEL	CFO and Treasuer	Mar 06 '24	Option Exercise	52.41	55,000	2,882,550	195,360	Mar 08 05:04 PM
Rodriguez Javier	Chief Executive Officer	Mar 06 '24	Option Exercise	67.80	750,000	50,850,000	1,244,480	Mar 08 05:04 PM
Rodriguez Javier	Chief Executive Officer	Feb 26 '24	Option Exercise	67.80	450,000	30,510,000	889,002	Feb 28 05:51 PM
Rodriguez Javier	Chief Executive Officer	Feb 28 '24	Option Exercise	67.80	50,000	3,390,000	531,300	Feb 28 05:51 PM
Rodriguez Javier	Chief Executive Officer	Feb 26 '24	Sale	126.11	67,603	8,525,130	488,697	Feb 28 05:51 PM
Rodriguez Javier	Chief Executive Officer	Feb 27 '24	Sale	126.87	7,397	938,467	481,300	Feb 28 05:51 PM
STAFFIERI MICHAEL DAVID	Chief Operating Officer, DKC	Feb 21 '24	Option Exercise	52.41	100,000	5,241,000	137,687	Feb 23 05:44 PM
STAFFIERI MICHAEL DAVID	Chief Operating Officer, DKC	Feb 21 '24	Sale	119.81	29,488	3,533,025	37,687	Feb 23 05:44 PM
Waters Kathleen Alyce	Chief Legal & Pub. Affairs Off	Feb 21 '24	Option Exercise	52.41	40,000	2,096,400	121,297	Feb 23 05:44 PM
Waters Kathleen Alyce	Chief Legal & Pub. Affairs Off	Feb 21 '24	Sale	120.73	11,285	1,362,438	81,297	Feb 23 05:44 PM
ACKERMAN JOEL	CFO and Treasuer	Feb 21 '24	Option Exercise	52.41	55,000	2,882,550	178,726	Feb 23 05:43 PM
HEARTY JAMES O	Chief Compliance Officer	Feb 16 '24	Option Exercise	54.40	54,608	2,970,478	78,448	Feb 20 08:37 PM
HEARTY JAMES O	Chief Compliance Officer	Feb 16 '24	Sale	119.64	26,164	3,130,269	20,264	Feb 20 08:37 PM
Rodriguez Javier	Chief Executive Officer	Dec 14 '23	Option Exercise	67.80	500,000	33,900,000	833,299	Dec 18 06:44 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DVA

DaVita Inc

Upgrade your FINVIZ experience